May 09, 2023 / 05:00PM GMT
Tazeen Ahmad - BofA Securities, Research Division - MD in Equity Research & Research Analyst
Thanks for joining us. I'm Tazeen Ahmad. I am one of the senior SMID biotech analyst here at Bank of America. Thanks for joining us at our conference again this year. It's my pleasure to present our next management team Neurocrine Biosciences. Sitting with me are too familiar gentlemen. To my left is Kevin Gorman, who is, of course, CEO; and to my right is Matt Abernethy, who is the Chief Financial Officer. Gentlemen, thanks for joining us again.
Kevin C. Gorman - Neurocrine Biosciences, Inc. - CEO & Director
Thank you very much, Tazeen, and also thank you for letting us speak here again.
Tazeen Ahmad - BofA Securities, Research Division - MD in Equity Research & Research Analyst
Of course. So I think, Kevin, at this point, most people know about the company and what it does, but maybe you could just give us a quick 1-minute intro about Neurocrine and then we can go straight into Q&A.
Kevin C.
Neurocrine Biosciences Inc at Bank of America Global Healthcare Conference Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers